Novus signs agreement with biotech firm
Novus International, Inc. announced a worldwide agreement today with emerging biotechnology company BioResource International, Inc (BRI). The signed agreement states that Novus will be the exclusive worldwide marketer for BRI’s patented enzyme technologies.
“We are pleased to enter into this partnership with Novus International to
bring value through improved feed efficiency solutions to the global
market,” stated Dr. Giles Shih, Co-founder and President of BioResource
International, Inc. “Novus brings strong customer relationships, technical
expertise in all areas of animal production, and a wide ranging global reach
that complement BRI’s strengths in the area of biotechnology development and
innovation.”
BRI’s enzymes provide animal producers with an excellent
source of versatile and pellet stable enzymes that allow them to achieve
improved animal performance and greater flexibility in dietary formulations.
“Novus is excited about bringing this technology into our CIBENZA feed additive
enzyme portfolio. It represents a strong strategic fit for our overall
portfolio and is aligned with our drive to bring advanced feed technologies to
the market,” stated Giovanni Gasperoni, Executive Vice President, Marketing and
Sales.
Related websites:
Novus International,
Inc.
BioResource International, Inc.
Join 26,000+ subscribers
Subscribe to our newsletter to stay updated about all the need-to-know content in the feed sector, three times a week.
